Abstract: “The Bethesda System for Reporting Thyroid Cytopathology”

Slides:

Advertisements

Similar presentations

Case 10 New Frontiers in Pathology, 2009 William G. Finn, M.D.

Advertisements

TA OGUNLESI (FWACP)1 CHILDHOOD LEUKAEMIA. TA OGUNLESI (FWACP)2 LEUKAEMIA Heterogenous group of malignant disorders Characterised by uncontrolled clonal.

ICCS e-newsletter CSI Spring 2012 Weina Chen, MD, PhD Medical Director, Hematopathology Ameripath/Quest Diagnostics Dallas, Texas.

Identification and Diagnosis of the Acute Leukemias

Multi-dimensional Genomic Profiling of Acute Leukemias Characterized by MLL gene rearrangements Eunice S. Wang MD (Medicine) and Norma J. Nowak PhD (Cancer.

Ian Jaffee, MD FCAP Director of Cytopathology

Chapter 25: Acute Lymphoblastic Leukemia. Causes a wide spectrum of syndromes – From involvement of bone marrow and peripheral blood(leukemias) to those.

Epidemiology of cancer:. Cancer incidence:  In males: Cancers of the lung, prostate, and colon are the leading causes of cancer deaths.  In females.

The acute Leukemias are clonal hematopoietic malignant disease that arise from the malignant T r a n s f o r m a t i o n of an early Hematopoietic stem.

Hematopoietic and Lymphoid Neoplasm Project. Acknowledgments American College of Surgeons (ACOS) Commission on Cancer (COC) Canadian Cancer Registries.

About these slides SPEC – Short Presentation in Emerging Concepts Provided by the CAP as an aid to pathologists to facilitate discussion on the topic.

Metastatic Cancer – Gross Pathology Lymph node - metastasis from breastLiver – metastasis from lung Vertebral column – metastasis from prostate Mesentery.

Rare mammary gland diseases: a continuous challenge for the clinician

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor.

Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.

Copyright © 2016 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill Education.

HIV D S O’Briain March Pathology of HIV Epidemic disease Influenza pandemic Legionnaire’s disease 1976 HIV 1981 Heroin, Dublin 2000 SARS.

MLAB 1415: Hematology Keri Brophy-Martinez

MLAB Hematology Keri Brophy-Martinez

Acute Leukemia Kristine Krafts, M.D..

Cancer 101 William E. Janssen, Ph.D. Director, Cell Therapies Facility Moffitt Cancer Center Cindy Eller VP for Development Roswell Park Cancer Institute.

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Neal I. Lindeman, Philip T. Cagle, Mary Beth.

Association of Clinical Status of Follicular Lymphoma Patients after Autologous Stem Cell Transplant and Quantitative Assessment of Lymphoma in Blood and.

Evidence of B Cell Immune Responses to Acute Lymphoblastic Leukemia in Murine Allogeneic Hematopoietic Stem Cell Transplantation Recipients Treated with.

The Role of Repeat Fine Needle Aspiration in Improving Diagnostic Accuracy in Thyroid Masses 1Laura Allen, 2Ayham Al Afif, 2Matthew H Rigby, 3Martin J.

Cytopathology Laboratory

Acute Leukemia Kristine Krafts, M.D..

Kazunori Kanehira, Douglas L. Riegert-Johnson, Dong Chen, Lawrence E

Materials and methods:

Cancer unchecked growth that progresses toward limitless expansion.

Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease.

Figure 2 Percentage of CD19+/CD34+ cells with decreased CD81 median fluorescence intensity (MFI;

Early T-Cell Precursor ALL in 5 Year Old Female

Evaluation of the Real-Q BRAF V600E Detection Assay in Fine-Needle Aspiration Samples of Thyroid Nodules Kyung Sun Park, Young L. Oh, Chang-Seok Ki,

Tissue Acquisition and Reflex Testing How do we Prioritize?

In Stem Cell Transplantation by Limiting the Morbidity of Graft-versus-Host Disease Tolerance to Myeloablative Conditioning is Improved Nicolas Novitzky,

Chimerism Monitoring after Allogeneic Hematopoietic Stem Cell Transplantation Using Quantitative Real-Time PCR of Biallelic Insertion/Deletion Polymorphisms

Intravenous Busulfan-Cyclophosphamide as a Preparative Regimen Before Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Acute.

B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality by Rachelle G. Veenstra, Ryan Flynn, Katharina.

Tissue acquisition and reflex testing. How do we prioritize?

Joanna Wang, Chetan Bettegowda The Journal of Molecular Diagnostics

Molecular Classifiers for Prediction of Minimal Residual Disease (MRD) and Event Free Survival (EFS) Improve Risk Assignment at Diagnosis in Pediatric.

Kazunori Kanehira, Douglas L. Riegert-Johnson, Dong Chen, Lawrence E

Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia Lan-Ping Xu, Zheng-Li Xu, Xiao-Hui Zhang, Huan.

The Henry Ford Production System: LEAN Process Redesign Improves Service in the Molecular Diagnostic Laboratory Milena Cankovic, Ruan C. Varney, Lisa.

Erythroid leukemia evolving from multiple myeloma

Spontaneous Autologous Graft-versus-Host Disease in Plasma Cell Myeloma Autograft Recipients: Flow Cytometric Analysis of Hematopoietic Progenitor Cell.

Development and Validation Of a Highly Sensitive and Specific Gene Expression Classifier To Prospectively Screen and Identify B-Precursor Acute Lymphoblastic.

Hematopoietic Cell Transplantation with and without Sorafenib Maintenance for Patients with FLT3-ITD Acute Myeloid Leukemia in CR1 Andrew M. Brunner,

Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia Vivian.

Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease.

Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease–Guided Multiple DLIs Could Improve Outcomes.

Donor Cell Leukemia in Umbilical Cord Blood Transplant Patients

A Practical Approach to the Detection of Prognostically Significant Genomic Aberrations in Multiple Myeloma Zhong Chen, Bonnie Issa, Shiang Huang, Emily.

Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in.

Neoplastic disorder.

Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell– Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous.

T Cell Receptor γ-Chain Gene Polymerase Chain Reaction to Diagnose Central Nervous System Involvement by Cutaneous T Cell Lymphoma Robert Taylor, Jo-Anne.

Clinical Lymphoma, Myeloma and Leukemia

Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-

Haploidentical/Mismatched Hematopoietic Stem Cell Transplantation without In Vitro T Cell Depletion for T Cell Acute Lymphoblastic Leukemia Yu Wang,

Clinical Utility of Computed Tomography Screening of Chest, Abdomen, and Sinuses before Hematopoietic Stem Cell Transplantation: The St. Jude Experience

The incidence and risk factors of invasive fungal infection after haploidentical haematopoietic stem cell transplantation without in vitro T-cell depletion

Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, and Clinical Significance Deborah.

Treatment of Autoimmune Disease by Intense Immunosuppressive Conditioning and Autologous Hematopoietic Stem Cell Transplantation by Richard K. Burt, Ann.

Early B-cell chronic lymphocytic leukemia presenting as cutaneous lesions with a normal peripheral blood lymphocyte count Simon D.J. Gibbs, MBBS, David.

Mary Eapen Biology of Blood and Marrow Transplantation

Myeloid neoplasms with eosinophilia

Presentation transcript:

Abstract: “The Bethesda System for Reporting Thyroid Cytopathology” November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “The Bethesda System for Reporting Thyroid Cytopathology” Edmund S. Cibas and Syed Z. Ali

Thierry Delorme, Stacy Rose, Julie Senita, Cynthia Callahan, November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Epidemiology and Susceptibilities of Methicillin-Resistant Staphylococcus aureus in Northeastern Ohio ” Thierry Delorme, Stacy Rose, Julie Senita, Cynthia Callahan, and Payman Nasr

Xiangrong Zhao, Damir Mazlagic, Ethan A. Flynn, Helda Hernandez, November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Is the QuantiFERON-TB Blood Assay a Good Replacement for the Tuberculin Skin Test in Tuberculosis Screening?” Xiangrong Zhao, Damir Mazlagic, Ethan A. Flynn, Helda Hernandez, and Charles L. Abbott

Robert F. Murphy and Angela M. Caliendo November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Relative Quantity of Cerebrospinal Fluid Herpes Simplex Virus DNA in Adult Cases of Encephalitis and Meningitis” Robert F. Murphy and Angela M. Caliendo

American Journal of Clinical Pathology November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Aberrant Underexpression of CD81 in Precursor B-Cell Acute Lymphoblastic Leukemia” Tariq Muzzafar, L. Jeffrey Medeiros, Sa A. Wang, Archana Brahmandam, Deborah A. Thomas, and Jeffrey L. Jorgensen

Abstract: “Immunophenotypic Variations in Mantle Cell Lymphoma” November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Immunophenotypic Variations in Mantle Cell Lymphoma” Juehua Gao, LoAnn Peterson, Beverly Nelson, Charles Goolsby, and Yi-Hua Chen

Abstract: “Lymphocyte-Depleted Thymic Remnants” November 2009; 132 (5) American Journal of Clinical Pathology November 2009; 132 (5) Abstract: “Lymphocyte-Depleted Thymic Remnants” Geoffrey A. Talmon and Jean E. Lewis

Milena Cankovic, Lisa Whiteley, Robert C. Hawley, Richard J. Zarbo, November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Clinical Performance of JAK2 V617F Mutation Detection Assays in a Molecular Diagnostics Laboratory” Milena Cankovic, Lisa Whiteley, Robert C. Hawley, Richard J. Zarbo, and Dhananjay Chitale

Catherine L. Salisbury, Steven D. Budnick, and Shiyong Li November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “T-Cell Receptor Gene Rearrangement and CD30 Immunoreactivity in Traumatic Ulcerative Granuloma With Stromal Eosinophilia of the Oral Cavity ” Catherine L. Salisbury, Steven D. Budnick, and Shiyong Li

Ritu Gupta, Archana Bhaskar, Lalit Kumar, Atul Sharma, November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Flow Cytometric Immunophenotyping and Minimal Residual Disease Analysis in Multiple Myeloma” Ritu Gupta, Archana Bhaskar, Lalit Kumar, Atul Sharma, and Paresh Jain

Franklin S. Fuda, Nitin J. Karandikar, and Weina Chen November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Significant CD5 Expression on Normal Stage 3 Hematogones and Mature B Lymphocytes in Bone Marrow” Franklin S. Fuda, Nitin J. Karandikar, and Weina Chen

Abstract: “Fine-Needle Aspiration Biopsy of Chondromyxoid Fibroma” November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Fine-Needle Aspiration Biopsy of Chondromyxoid Fibroma” Simon Bergman, Christopher R. Madden, and Kim R. Geisinger

American Journal of Clinical Pathology November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Time Trends in Fungal Infections as a Cause of Death in Hematopoietic Stem Cell Transplant Recipients” Mariam Alsharif, Stuart E. H. Cameron, Jo-Anne H. Young, Kay Savik, Jonathan C. Henriksen, H. Evin Gulbahce, and Stefan E. Pambuccian

American Journal of Clinical Pathology November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Evaluation of Cell Surface Expression of Phosphatidylserine in Ovarian Carcinoma Effusions Using the Annexin-V/7-AAD Assay” Hiep Phuc Dong, Arild Holth, Lilach Kleinberg, Marit Gunhild Ruud, Mari Bunkholt Elstrand, Claes G. Tropé, Ben Davidson, and Björn Risberg

Megan A. Renshaw, Andrew A. Renshaw, and Edwin W. Gould November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Should Pathologists Send All or Only Selected Slides for Patient-Requested Interlaboratory Second Opinion?” Megan A. Renshaw, Andrew A. Renshaw, and Edwin W. Gould

Abstract: “The Becton Dickinson FocalPoint GS Imaging System” November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “The Becton Dickinson FocalPoint GS Imaging System” David C. Wilbur, W. Stephen Black-Schaffer, Ronald D. Luff, Kurian P. Abraham, Cynthia Kemper, James T. Molina, and William D. Tench

American Journal of Clinical Pathology November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “p16INK4a Expression Analysis as an Ancillary Tool for Cytologic Diagnosis of Urothelial Carcinoma ” Kumiko Nakazawa, Shin-ichi Murata, Tsutomu Yuminamochi, Yoshio Ishii, Shikine Ohno, Tadao Nakazawa,Tetsuo Kondo, and Ryohei Katoh

American Journal of Clinical Pathology November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Accuracy of Urine Cytology and the Significance of an Atypical Category” Fadi Brimo, Robin T. Vollmer, Bruce Case, Armen Aprikian, Wassim Kassouf, and Manon Auger

Abstract: “Embolization of Hydrophilic Catheter Coating to the Lungs” November 2009; 132 (5) American Journal of Clinical Pathology Abstract: “Embolization of Hydrophilic Catheter Coating to the Lungs” Robert W. Allan, Hassan Alnuaimat, William D. Edwards, and Henry D. Tazelaar